The EsophyX2 HD received FDA 510(k) clearance in September. The new product is designed to offer physicians use a larger range of endoscopes when performing transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.
“Now, physicians with either traditional scopes or the latest endoscopic imaging technology may choose the scientifically proven TIF procedure for select patients,” said EndoGastric Solutions President and CEO Skip Baldino.
More articles on gastroenterology:
23 GI-driven ASCs & facilities opened or announced in 2014
Physicians vs. computers: Who creates better patient reports?
8 gastroenterologist moves & honors
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.